Maximus Inc. (NYSE:MMS) Given Consensus Recommendation of “Buy” by Analysts
Maximus Inc. (NYSE:MMS) has earned a consensus recommendation of “Buy” from the ten brokerages that are covering the stock. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $65.75.
Several equities analysts have weighed in on the company. Maxim Group lifted their price objective on Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a report on Thursday, August 4th. KeyCorp assumed coverage on Maximus in a report on Monday, July 11th. They issued a “buy” rating for the company. Finally, Zacks Investment Research cut Maximus from a “hold” rating to a “sell” rating in a report on Wednesday, August 3rd.
In related news, Director Paul R. Lederer sold 500 shares of the business’s stock in a transaction on Friday, August 26th. The stock was sold at an average price of $59.15, for a total transaction of $29,575.00. Following the sale, the director now owns 74,674 shares in the company, valued at approximately $4,416,967.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Bruce Caswell sold 30,000 shares of the business’s stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $58.98, for a total value of $1,769,400.00. Following the sale, the president now owns 39,386 shares in the company, valued at approximately $2,322,986.28. The disclosure for this sale can be found here. Corporate insiders own 3.60% of the company’s stock.
Large investors have recently modified their holdings of the company. FMR LLC raised its stake in shares of Maximus by 17.4% in the second quarter. FMR LLC now owns 5,269,547 shares of the company’s stock worth $291,775,000 after buying an additional 780,765 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Maximus by 67.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,211,350 shares of the company’s stock worth $63,765,000 after buying an additional 488,027 shares during the period. FIL Ltd raised its stake in Maximus by 171.8% in the second quarter. FIL Ltd now owns 716,824 shares of the company’s stock worth $39,690,000 after buying an additional 453,116 shares during the period. Makaira Partners LLC bought a new stake in Maximus during the first quarter worth approximately $23,251,000. Finally, Emerald Acquisition Ltd. bought a new stake in Maximus during the second quarter worth approximately $21,558,000. Institutional investors and hedge funds own 99.00% of the company’s stock.
Shares of Maximus (NYSE:MMS) traded down 1.12% during trading on Thursday, hitting $54.96. The stock had a trading volume of 150,116 shares. The stock has a market capitalization of $3.57 billion, a price-to-earnings ratio of 22.46 and a beta of 1.15. The stock has a 50 day moving average price of $57.63 and a 200-day moving average price of $55.77. Maximus has a one year low of $45.15 and a one year high of $69.85.
Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 4th. The company reported $0.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.04. The firm earned $617.10 million during the quarter, compared to analysts’ expectations of $625.62 million. Maximus had a return on equity of 23.89% and a net margin of 6.91%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.62 EPS. On average, equities research analysts predict that Maximus will post $2.65 earnings per share for the current year.
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.